PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spinoff from Becton, Dickinson and Company ("BD"), today held a grand opening ceremony at its new global headquarters office at 300 Kimball Drive, Suite 300, in Parsippany, N.J. The site will be home to members of the leadership team, global support functions and the North America commercial organization. embecta has approximately 2,000 employees worldwide.
"With a number of our employees currently making their homes in New Jersey, the ability to tap into one of the nation's most significant concentrations of highly-educated, experienced medical technology talent, and easy access to international airports and interstate highways, we see Parsippany as the ideal location to establish our worldwide headquarters," said Devdatt (Dev) Kurdikar, president and chief executive officer, embecta. "We are a new company, but our roots in New Jersey go back nearly 100 years when, as part of BD, we developed the first dedicated insulin syringe in 1924. We're looking forward to advancing that legacy as we continue to develop and provide solutions that make life better for people living with diabetes."
The 55,600-square-foot office suite is designed to give employees the tools and flexibility they need to collaborate both in-person and on a global scale as they work with geographically dispersed teams to meet the needs of customers in over 100 countries. In addition to ample open workspace, the suite features numerous spaces for collaboration with the latest video conferencing technology, huddle rooms, and reservable private spaces, as well as a showroom for product demonstrations and on-site customer meetings. CBRE, the world's largest commercial real estate services and investment firm, has been embecta's partner in choosing, designing and building out the office.
"We're pleased that embecta has chosen to make a long-term commitment to New Jersey, adding to the roster of life sciences and medical technology companies that make the core of the Garden State's innovation economy," said Governor Phil Murphy. "Diabetes is one of the world's most pressing health care issues, with an enormous cost burden and a societal impact that extends to friends, loved ones and caregivers. embecta's vision of a life unlimited by diabetes is closely aligned with our own efforts to invest in, and expand, the state's public health infrastructure."
About embecta
embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com, the content of which is not a part of this press release.
CONTACTS
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR
Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations
新泽西州帕西帕尼,2023年1月25日(Global Newswire)--Embecta Corp.(“Embecta”)(纳斯达克股票代码:EMBC)是继2022年4月1日从Becton,Dickinson and Company(“BD”)剥离出来的全球最大的糖尿病护理公司之一,今天在其位于新泽西州帕西帕尼金博尔大道300号Suite 300的新全球总部举行了隆重的开业仪式。该办公室将容纳领导团队成员、全球支持职能部门和北美商业组织成员。Embecta在全球拥有约2,000名员工。
Embecta首席执行官总裁和德维达特(Dev)库尔迪卡说:“我们的许多员工目前在新泽西州安家,能够进入美国最重要的受过高等教育、经验丰富的医疗技术人才的集中地区之一,而且很容易到达国际机场和州际高速公路,我们认为帕西帕尼是建立我们全球总部的理想地点。”我们是一家新公司,但我们在新泽西州的根可以追溯到近100年前,当时,作为BD的一部分,我们在1924年开发了第一个专用胰岛素注射器。我们期待着在继续开发和提供解决方案,使糖尿病患者的生活更美好的同时,发扬这一遗产。
这个55,600平方英尺的办公套件旨在为员工提供所需的工具和灵活性,以便在他们与地理上分散的团队合作以满足100多个国家/地区客户的需求时进行面对面和全球范围的协作。除了宽敞的开放式工作空间外,该套房还配有大量使用最新视频会议技术进行协作的空间、休息室和可预留的私人空间,以及用于产品演示和现场客户会议的展示厅。世邦魏理仕是世界上最大的商业地产服务和投资公司,一直是Embecta的合作伙伴,负责办公室的选择、设计和建设。
州长菲尔·墨菲表示:“我们很高兴Embecta选择对新泽西州做出长期承诺,加入生命科学和医疗技术公司的行列,这些公司构成了花园州创新经济的核心。”糖尿病是世界上最紧迫的医疗保健问题之一,具有巨大的成本负担和社会影响,延伸到朋友、亲人和照顾者。Embecta的愿景是不受糖尿病限制的生活,这与我们自己投资和扩大国家公共卫生基础设施的努力密切相关。
关于Embecta
Embecta是世界上最大的纯糖尿病护理公司之一,利用其在胰岛素输送方面近100年的历史,通过创新的解决方案、合作伙伴关系和全球约2,000名员工的热情,使糖尿病患者能够过上最好的生活。欲了解更多信息,请访问www.embecta.com,该网站的内容不在本新闻稿中。
联系人:
投资者:
普拉维什·坎德尔瓦尔
投资者关系副总裁兼主管
551-264-6547
联系IR
媒体:
克里斯蒂安·格拉扎
高级董事,企业通联部
电话:908-821-6922
联系媒体关系